1-112956232-CG-CGG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The ENST00000429288.2(SLC16A1):​c.-45+606_-45+607insC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00995 in 153,310 control chromosomes in the GnomAD database, including 26 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 26 hom., cov: 31)
Exomes 𝑓: 0.0027 ( 0 hom. )

Consequence

SLC16A1
ENST00000429288.2 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.424

Publications

0 publications found
Variant links:
Genes affected
SLC16A1 (HGNC:10922): (solute carrier family 16 member 1) The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]
SLC16A1-AS1 (HGNC:49445): (SLC16A1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-112956232-C-CG is Benign according to our data. Variant chr1-112956232-C-CG is described in ClinVar as [Likely_benign]. Clinvar id is 291916.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.01 (1523/152204) while in subpopulation AFR AF = 0.0339 (1410/41538). AF 95% confidence interval is 0.0325. There are 26 homozygotes in GnomAd4. There are 715 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AD,AR,Unknown,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC16A1NM_003051.4 linkc.-243_-242insC upstream_gene_variant ENST00000369626.8 NP_003042.3 P53985-1A0A024R0H1
SLC16A1NM_001166496.2 linkc.-1002_-1001insC upstream_gene_variant NP_001159968.1 P53985-1A0A024R0H1B4DKS0
SLC16A1-AS1NR_103743.1 linkn.-183_-182insG upstream_gene_variant
SLC16A1-AS1NR_103744.1 linkn.-183_-182insG upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC16A1ENST00000369626.8 linkc.-243_-242insC upstream_gene_variant 1 NM_003051.4 ENSP00000358640.4 P53985-1

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1522
AN:
152088
Hom.:
26
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0340
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000388
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.00669
GnomAD4 exome
AF:
0.00271
AC:
3
AN:
1106
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
608
show subpopulations
African (AFR)
AF:
0.0167
AC:
1
AN:
60
American (AMR)
AF:
0.0385
AC:
1
AN:
26
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
46
East Asian (EAS)
AF:
0.00
AC:
0
AN:
52
South Asian (SAS)
AF:
0.00
AC:
0
AN:
10
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
54
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
8
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
786
Other (OTH)
AF:
0.0156
AC:
1
AN:
64
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.708
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0100
AC:
1523
AN:
152204
Hom.:
26
Cov.:
31
AF XY:
0.00961
AC XY:
715
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0339
AC:
1410
AN:
41538
American (AMR)
AF:
0.00458
AC:
70
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000389
AC:
2
AN:
5146
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.0205
AC:
6
AN:
292
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68000
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
76
153
229
306
382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0112
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 10, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hyperinsulinism, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.42
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58047463; hg19: chr1-113498854; API